Linked Life Data

19892235

Source:http://linkedlifedata.com/resource/pubmed/id/19892235

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
20
pubmed:dateCreated
2009-11-6
pubmed:abstractText
We investigated whether plasma amino-terminal pro-brain natriuretic peptide (NT-proBNP), a marker of cardiac dysfunction and prognosis measured in CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure), could be used to identify the severity of heart failure at which statins become ineffective.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1558-3597
pubmed:author
pubmed:copyrightInfo
2009 by the American College of Cardiology Foundation
pubmed:issnType
Electronic
pubmed:day
10
pubmed:volume
54
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1850-9
pubmed:dateRevised
2010-4-9
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure).
pubmed:affiliation
Department of Cardiology, University of Hull, Kingston-upon-Hull, United Kingdom. j.g.cleland@hull.ac.uk
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study